Simultaneous assessment of targeted anticancer therapy-associated mucocutaneous adverse events.

e20669 Background: Mucocutaneous adverse events (mcAEs), including papulopustular rash, xerosis, pruritus, paronychia, hand-foot skin reaction, edema, taste alterations, oral pain and ulceration, h...